pre_text: abiomed , inc . and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 3 . acquisitions ( continued ) including the revenues of third-party licensees , or ( ii ) the company 2019s sale of ( a ) ecp , ( b ) all or substantially all of ecp 2019s assets , or ( c ) certain of ecp 2019s patent rights , the company will pay to syscore the lesser of ( x ) one-half of the profits earned from such sale described in the foregoing item ( ii ) , after accounting for the costs of acquiring and operating ecp , or ( y ) $ 15.0 million ( less any previous milestone payment ) . ecp 2019s acquisition of ais gmbh aachen innovative solutions in connection with the company 2019s acquisition of ecp , ecp acquired all of the share capital of ais gmbh aachen innovative solutions ( 201cais 201d ) , a limited liability company incorporated in germany , pursuant to a share purchase agreement dated as of june 30 , 2014 , by and among ecp and ais 2019s four individual shareholders . ais , based in aachen , germany , holds certain intellectual property useful to ecp 2019s business , and , prior to being acquired by ecp , had licensed such intellectual property to ecp . the purchase price for the acquisition of ais 2019s share capital was approximately $ 2.8 million in cash , which was provided by the company , and the acquisition closed immediately prior to abiomed europe 2019s acquisition of ecp . the share purchase agreement contains representations , warranties and closing conditions customary for transactions of its size and nature . purchase price allocation the acquisition of ecp and ais was accounted for as a business combination . the purchase price for the acquisition has been allocated to the assets acquired and liabilities assumed based on their estimated fair values . the acquisition-date fair value of the consideration transferred is as follows : acquisition date fair value ( in thousands ) .
post_text: .
table: Total Acquisition Date Fair Value (in thousands)
table: Cash consideration $15,750
table: Contingent consideration 6,000
table: Total consideration transferred $21,750
question: Analyse this data from a financial earnings document. for the ecp and ais transactions , what portion of the total consideration was paid immediately in cash?